Skip to main content
. 2021 Apr 23;10(2):435–454. doi: 10.1007/s40120-021-00243-6

Fig. 3.

Fig. 3

Minimum washout times following discontinuation of a disease-modifying therapy and administration of cladribine tablets. aNote that lymphocytes must be normal before initiating cladribine tablets irrespective of waiting times shown here. bAssumes the rapid elimination procedure for teriflunomide is used